BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 38812486)

  • 1. Educating the next generation of psychiatrists in the use of clinical neuromodulation therapies: what should all psychiatry residents know?
    Menon SN; Torrico T; Luber B; Gindoff B; Cullins L; Regenold W; Lisanby SH
    Front Psychiatry; 2024; 15():1397102. PubMed ID: 38812486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Efficacy and Safety of Neuromodulation Treatments in Late-Life Depression.
    van Rooij SJH; Riva-Posse P; McDonald WM
    Curr Treat Options Psychiatry; 2020 Sep; 7(3):337-348. PubMed ID: 33585164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vagus Nerve Stimulation (VNS) and Treatment of Depression: To the Brainstem and Beyond.
    O'Reardon JP; Cristancho P; Peshek AD
    Psychiatry (Edgmont); 2006 May; 3(5):54-63. PubMed ID: 21103178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurostimulation Therapies.
    Trapp NT; Xiong W; Conway CR
    Handb Exp Pharmacol; 2019; 250():181-224. PubMed ID: 30294765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroimaging and neuromodulation approaches to study eating behavior and prevent and treat eating disorders and obesity.
    Val-Laillet D; Aarts E; Weber B; Ferrari M; Quaresima V; Stoeckel LE; Alonso-Alonso M; Audette M; Malbert CH; Stice E
    Neuroimage Clin; 2015; 8():1-31. PubMed ID: 26110109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced training in interventional psychiatry.
    Nikayin S; Taylor JJ; Ostroff RB
    J Neurol Sci; 2022 Mar; 434():120093. PubMed ID: 34974201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromodulation techniques for status epilepticus: A review.
    San-Juan D; Dávila-Rodríguez DO; Jiménez CR; González MS; Carranza SM; Hernández Mendoza JR; Anschel DJ
    Brain Stimul; 2019; 12(4):835-844. PubMed ID: 31053521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromodulation approaches for the treatment of major depression: challenges and recommendations from a working group meeting.
    Brunoni AR; Teng CT; Correa C; Imamura M; Brasil-Neto JP; Boechat R; Rosa M; Caramelli P; Cohen R; Del Porto JA; Boggio PS; Fregni F
    Arq Neuropsiquiatr; 2010 Jun; 68(3):433-51. PubMed ID: 20602051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroinflammation mechanisms of neuromodulation therapies for anxiety and depression.
    Guo B; Zhang M; Hao W; Wang Y; Zhang T; Liu C
    Transl Psychiatry; 2023 Jan; 13(1):5. PubMed ID: 36624089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic therapies for treatment-resistant depression: ECT, TMS, VNS, DBS.
    Cusin C; Dougherty DD
    Biol Mood Anxiety Disord; 2012 Aug; 2():14. PubMed ID: 22901565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromodulation techniques - From non-invasive brain stimulation to deep brain stimulation.
    Davidson B; Bhattacharya A; Sarica C; Darmani G; Raies N; Chen R; Lozano AM
    Neurotherapeutics; 2024 Apr; 21(3):e00330. PubMed ID: 38340524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromodulatory treatments for psychiatric disease: A comprehensive survey of the clinical trial landscape.
    Elias GJB; Boutet A; Parmar R; Wong EHY; Germann J; Loh A; Paff M; Pancholi A; Gwun D; Chow CT; Gouveia FV; Harmsen IE; Beyn ME; Santarnecchi E; Fasano A; Blumberger DM; Kennedy SH; Lozano AM; Bhat V
    Brain Stimul; 2021; 14(5):1393-1403. PubMed ID: 34461326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcranial magnetic stimulation, deep brain stimulation, and other forms of neuromodulation for substance use disorders: Review of modalities and implications for treatment.
    Mahoney JJ; Hanlon CA; Marshalek PJ; Rezai AR; Krinke L
    J Neurol Sci; 2020 Nov; 418():117149. PubMed ID: 33002757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary Approaches Toward Neuromodulation of Fear Extinction and Its Underlying Neural Circuits.
    Becker CR; Milad MR
    Curr Top Behav Neurosci; 2023; 64():353-387. PubMed ID: 37658219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromodulation Treatments for Geriatric Mood and Cognitive Disorders.
    McDonald WM
    Am J Geriatr Psychiatry; 2016 Dec; 24(12):1130-1141. PubMed ID: 27889282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of neuromodulation in the management of drug-resistant epilepsy.
    Salama H; Salama A; Oscher L; Jallo GI; Shimony N
    Neurol Sci; 2024 Apr; ():. PubMed ID: 38642321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review on neuromodulation therapies for reducing body weight in patients with obesity.
    Gouveia FV; Silk E; Davidson B; Pople CB; Abrahao A; Hamilton J; Ibrahim GM; Müller DJ; Giacobbe P; Lipsman N; Hamani C
    Obes Rev; 2021 Oct; 22(10):e13309. PubMed ID: 34337843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Training the next generation of providers in addiction medicine.
    Rasyidi E; Wilkins JN; Danovitch I
    Psychiatr Clin North Am; 2012 Jun; 35(2):461-80. PubMed ID: 22640766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective, naturalistic study of deep brain stimulation and vagal nerve stimulation in young patients.
    Yuruk D; Ozger C; Garzon JF; Nakonezny PA; Vande Voort JL; Croarkin PE
    Brain Behav; 2024 Mar; 14(3):e3452. PubMed ID: 38468454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.